TP63 (tumor protein p63) - Rat Genome Database

Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: TP63 (tumor protein p63) Homo sapiens
Symbol: TP63
Name: tumor protein p63
RGD ID: 1604844
HGNC Page HGNC:15979
Description: Enables several functions, including MDM2/MDM4 family protein binding activity; WW domain binding activity; and p53 binding activity. Involved in several processes, including negative regulation of cellular senescence; positive regulation of fibroblast apoptotic process; and regulation of DNA-templated transcription. Located in chromatin; cytoplasm; and nucleoplasm. Implicated in several diseases, including ADULT syndrome; EEC syndrome (multiple); ectodermal dysplasia (multiple); orofacial cleft 8; and split hand-foot malformation 4. Biomarker of cervix uteri carcinoma in situ; prostate carcinoma in situ; and urinary bladder cancer.
Type: protein-coding
RefSeq Status: REVIEWED
Previously known as: AIS; amplified in squamous cell carcinoma; B(p51A); B(p51B); chronic ulcerative stomatitis protein; CUSP; EEC3; keratinocyte transcription factor KET; KET; LMS; NBP; OFC8; p40; p51; p53CP; p63; p73H; p73L; RHS; SHFM4; TP53CP; TP53L; TP73L; transformation-related protein 63; tumor protein 63; tumor protein p53-competing protein; tumor protein p53-like; tumor protein p63 deltaN isoform delta; tumor protein p73-like
RGD Orthologs
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Human AssemblyChrPosition (strand)SourceGenome Browsers
GRCh383189,596,746 - 189,897,276 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p13 Ensembl3189,631,389 - 189,897,276 (+)EnsemblGRCh38hg38GRCh38
GRCh373189,314,535 - 189,615,065 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 363190,831,910 - 191,097,759 (+)NCBINCBI36Build 36hg18NCBI36
Celera3187,783,803 - 188,042,610 (+)NCBICelera
Cytogenetic Map3q28NCBI
HuRef3186,752,882 - 187,012,887 (+)NCBIHuRef
CHM1_13189,312,090 - 189,577,623 (+)NCBICHM1_1
T2T-CHM13v2.03192,413,470 - 192,713,713 (+)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)

Disease Annotations     Click to see Annotation Detail View
adenocarcinoma  (EXP)
ADULT syndrome  (IAGP)
amenorrhea  (IAGP)
ankyloblepharon-ectodermal defects-cleft lip/palate syndrome  (EXP,IAGP)
autosomal recessive nonsyndromic deafness  (IAGP)
bladder exstrophy  (ISS)
bladder exstrophy-epispadias-cloacal exstrophy complex  (IAGP)
bone development disease  (IAGP)
breast disease  (EXP)
Breast Neoplasms  (ISO)
carcinoma  (EXP)
cervix uteri carcinoma in situ  (IEP)
cleft lip  (EXP,IAGP)
Cleft Lip with or without Cleft Palate, Nonsyndromic, 8  (IAGP)
cleft palate  (EXP)
Colorectal Neoplasms  (EXP)
Congenital Foot Deformities  (EXP)
Congenital Hand Deformities  (EXP)
Congenital Limb Deformities  (EXP,IAGP)
Corneal Injuries  (ISO)
Craniofacial Abnormalities  (EXP)
ectodermal dysplasia  (IAGP)
ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3  (EXP,IAGP)
EEC syndrome  (EXP,IAGP,ISO)
Experimental Diabetes Mellitus  (ISO)
Experimental Neoplasms  (ISO)
Female Urogenital Diseases  (EXP)
fissured tongue  (IAGP)
gastroesophageal reflux disease  (ISS)
genetic disease  (IAGP)
Limb-Mammary Syndrome  (EXP,IAGP)
lung adenocarcinoma  (EXP)
lung cancer  (IAGP)
Lung Neoplasms  (EXP)
Multiple Abnormalities  (EXP)
muscular dystrophy  (IAGP)
Neoplasm Metastasis  (EXP)
Neoplastic Cell Transformation  (EXP)
orofacial cleft 8  (IAGP)
Ovarian Neoplasms  (EXP,IAGP)
pancreatic cancer  (EXP)
primary ovarian insufficiency  (IAGP)
prostate cancer  (IAGP)
prostate carcinoma in situ  (IEP,ISO)
Prostatic Neoplasms  (IEP,ISO)
Rapp-Hodgkin syndrome  (EXP,IAGP)
schizophrenia  (IAGP)
Skin Abnormalities  (EXP)
split hand-foot malformation  (IAGP)
split hand-foot malformation 4  (EXP,IAGP)
squamous cell carcinoma  (EXP)
squamous cell neoplasm  (EXP)
Sweat Gland Neoplasms  (EXP)
transitional cell carcinoma  (IMP)
urinary bladder cancer  (IEP)
Urologic Neoplasms  (IEP)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane  (ISO)
1,2-dibromoethane  (ISO)
1,2-dichloroethane  (ISO)
17beta-estradiol  (EXP)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,4-diaminotoluene  (ISO)
2-hydroxypropanoic acid  (EXP)
3,4-dichloroaniline  (ISO)
4,4'-sulfonyldiphenol  (ISO)
4-hydroxynon-2-enal  (EXP)
4-vinylcyclohexene dioxide  (ISO)
acrylamide  (ISO)
afimoxifene  (EXP)
aflatoxin B1  (EXP)
Aflatoxin B2 alpha  (EXP)
all-trans-retinoic acid  (EXP,ISO)
ammonium chloride  (ISO)
antimonite  (EXP)
antirheumatic drug  (EXP)
apigenin  (EXP)
arsenite(3-)  (EXP)
arsenous acid  (EXP)
benzo[a]pyrene  (EXP,ISO)
bis(2-chloroethyl) sulfide  (ISO)
bisphenol A  (EXP,ISO)
bisphenol F  (EXP,ISO)
butan-1-ol  (EXP)
butane-2,3-dione  (EXP)
cadmium atom  (EXP)
cadmium dichloride  (EXP)
calcitriol  (EXP)
camptothecin  (EXP)
carbon nanotube  (ISO)
CGP 52608  (EXP)
chloropicrin  (EXP)
chrysin  (EXP)
cisplatin  (EXP)
cobalt dichloride  (EXP)
copper atom  (EXP)
copper(0)  (EXP)
copper(II) sulfate  (EXP)
crocidolite asbestos  (EXP)
cycloheximide  (EXP)
diarsenic trioxide  (EXP)
dibenzo[a,l]pyrene  (ISO)
dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate  (EXP)
diuron  (ISO)
dorsomorphin  (EXP)
emodin  (ISO)
entinostat  (EXP)
ethanol  (EXP)
ethyl methanesulfonate  (EXP)
ethylenediaminetetraacetic acid  (EXP)
eugenol  (EXP)
formaldehyde  (EXP)
fulvestrant  (EXP)
Fusarenone X  (ISO)
genistein  (EXP,ISO)
glycidol  (ISO)
graphite  (ISO)
hydroxyurea  (ISO)
isobutanol  (EXP)
kaempferol  (EXP)
ketoconazole  (ISO)
lactacystin  (EXP)
lead diacetate  (ISO)
leptomycin B  (EXP)
lipopolysaccharide  (EXP)
lithium chloride  (EXP)
luteolin  (EXP)
melphalan  (EXP)
methyl methanesulfonate  (EXP)
methylmercury chloride  (ISO)
myricetin  (EXP)
N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal  (EXP)
nickel dichloride  (EXP)
Octicizer  (EXP)
panobinostat  (EXP)
paracetamol  (ISO)
perfluorooctane-1-sulfonic acid  (ISO)
phenylmercury acetate  (EXP)
progesterone  (EXP)
quercetin  (EXP)
quercitrin  (EXP)
quinolin-8-ol  (ISO)
rac-lactic acid  (EXP)
resveratrol  (EXP)
S-(1,2-dichlorovinyl)-L-cysteine  (EXP)
SB 431542  (EXP)
silicon dioxide  (EXP)
sirolimus  (EXP,ISO)
sodium arsenate  (ISO)
sodium arsenite  (EXP)
titanium dioxide  (ISO)
topotecan  (EXP)
trichloroethene  (ISO)
trichostatin A  (EXP)
trimellitic anhydride  (ISO)
troglitazone  (EXP)
urethane  (EXP)
valproic acid  (EXP)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
aging  (IEA,ISO)
anatomical structure formation involved in morphogenesis  (IEA,ISO)
animal organ morphogenesis  (IEA,ISO)
apoptotic process  (IEA,ISO,TAS)
cell population proliferation  (IEA)
cellular response to DNA damage stimulus  (IDA)
cellular senescence  (IEA,ISO)
chromatin remodeling  (IEA,ISO)
cloacal septation  (IEA,ISO)
cranial skeletal system development  (IEA,ISO)
developmental process  (IEA)
ectoderm and mesoderm interaction  (IEA,ISO)
embryonic forelimb morphogenesis  (IEA,ISO)
embryonic hindlimb morphogenesis  (IEA,ISO)
embryonic limb morphogenesis  (IEA,ISO)
epidermal cell differentiation  (IEA,ISO)
epidermal cell division  (IEA,ISO)
epidermis development  (IEA,ISO)
epithelial cell apoptotic process  (ISO)
epithelial cell development  (IEA,ISO)
epithelial cell differentiation  (IEA,ISO)
establishment of planar polarity  (IEA,ISO)
establishment of skin barrier  (IEA,ISS)
female genitalia morphogenesis  (IEA,ISO)
hair follicle development  (IEA,ISO)
hair follicle morphogenesis  (IEA,ISO)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator  (IEA,ISO)
keratinocyte development  (ISO)
keratinocyte differentiation  (IEA,ISO)
keratinocyte proliferation  (IEA,ISO)
morphogenesis of a polarized epithelium  (IEA,ISO)
multicellular organism aging  (IEA,ISO)
negative regulation of cellular senescence  (IMP)
negative regulation of DNA-templated transcription  (IDA)
negative regulation of epithelial cell apoptotic process  (ISO)
negative regulation of intracellular estrogen receptor signaling pathway  (IEA)
negative regulation of keratinocyte differentiation  (IEA,ISO)
negative regulation of mesoderm development  (IEA,ISO)
negative regulation of transcription by RNA polymerase II  (IEA,ISO)
neuron apoptotic process  (IEA,ISO)
Notch signaling pathway  (IEA,ISO)
obsolete cell aging  (IEA)
odontogenesis of dentin-containing tooth  (IEA,ISO)
pattern specification process  (IEA,ISO)
polarized epithelial cell differentiation  (IEA,ISO)
positive regulation of apoptotic signaling pathway  (IEA,ISO)
positive regulation of cell cycle G1/S phase transition  (IMP)
positive regulation of cell population proliferation  (IEA,ISO)
positive regulation of DNA-templated transcription  (IDA,IEA,IMP,NAS)
positive regulation of fibroblast apoptotic process  (IDA)
positive regulation of keratinocyte proliferation  (IEA,ISO)
positive regulation of mesenchymal cell proliferation  (ISO)
positive regulation of Notch signaling pathway  (IDA,IEA,ISO)
positive regulation of osteoblast differentiation  (IMP)
positive regulation of somatic stem cell population maintenance  (IEA)
positive regulation of stem cell proliferation  (IEA,ISO)
positive regulation of transcription by RNA polymerase II  (IDA,IEA,ISO)
post-anal tail morphogenesis  (IEA,ISO)
prostate gland development  (IEA,ISO)
prostatic bud formation  (IEA,ISO)
protein tetramerization  (IEA)
proximal/distal pattern formation  (IEA,ISO)
regulation of cysteine-type endopeptidase activity involved in apoptotic process  (IEA,ISO)
regulation of DNA-templated transcription  (IEA)
regulation of epidermal cell division  (IEA,ISS)
regulation of transcription by RNA polymerase II  (IBA)
skeletal system development  (IEA,ISO)
skin epidermis development  (IEA,ISO)
skin morphogenesis  (IEA,ISO)
smooth muscle tissue development  (ISO)
spermatogenesis  (IEA,ISO)
squamous basal epithelial stem cell differentiation involved in prostate gland acinus development  (IEA,ISO)
stem cell differentiation  (IEA,ISO)
stem cell proliferation  (IEA,ISO)
sympathetic nervous system development  (IEA,ISO)
transcription by RNA polymerase II  (IEA,ISO)
urinary bladder development  (ISO)

Cellular Component
chromatin  (IDA,ISA)
cytoplasm  (IDA,IEA)
dendrite  (IEA,ISO)
neuron projection  (IEA,ISO)
nucleoplasm  (IDA,TAS)
nucleus  (IDA,IEA,ISO,NAS)
protein-containing complex  (IEA,ISO)
rough endoplasmic reticulum  (IEA,ISO)

Molecular Pathway Annotations     Click to see Annotation Detail View
Phenotype Annotations     Click to see Annotation Detail View

Human Phenotype
2-3 toe cutaneous syndactyly  (IAGP)
2-3 toe syndactyly  (IAGP)
3-4 finger cutaneous syndactyly  (IAGP)
Abnormal dental enamel morphology  (IAGP)
Abnormal Eustachian tube morphology  (IAGP)
Abnormal nasal septum morphology  (IAGP)
Abnormal nasopharynx morphology  (IAGP)
Abnormal number of permanent teeth  (IAGP)
Abnormal pattern of respiration  (IAGP)
Abnormality of dental eruption  (IAGP)
Abnormality of dental morphology  (IAGP)
Abnormality of masticatory muscle  (IAGP)
Abnormality of the anus  (IAGP)
Abnormality of the clitoris  (IAGP)
Abnormality of the inner ear  (IAGP)
Abnormality of the middle ear  (IAGP)
Abnormality of the nervous system  (IAGP)
Absence of Stensen duct  (IAGP)
Absent eyelashes  (IAGP)
Absent hand  (IAGP)
Absent lacrimal punctum  (IAGP)
Absent nipple  (IAGP)
Adermatoglyphia  (IAGP)
Agenesis of lateral incisor  (IAGP)
Alopecia  (IAGP)
Alopecia of scalp  (IAGP)
Amniotic constriction ring  (IAGP)
Anal stenosis  (IAGP)
Anhidrotic ectodermal dysplasia  (IAGP)
Aniridia  (IAGP)
Ankyloblepharon  (IAGP)
Anonychia  (IAGP)
Anteriorly placed anus  (IAGP)
Aplasia of the ovary  (IAGP)
Aplasia of the uterus  (IAGP)
Aplasia/Hypoplasia involving the metacarpal bones  (IAGP)
Aplasia/Hypoplasia of metatarsal bones  (IAGP)
Aplasia/Hypoplasia of the breasts  (IAGP)
Aplasia/Hypoplasia of the nipples  (IAGP)
Aplasia/Hypoplasia of the phalanges of the hand  (IAGP)
Aplasia/Hypoplasia of the phalanges of the toes  (IAGP)
Aplasia/Hypoplasia of the skin  (IAGP)
Aplasia/Hypoplasia of the thumb  (IAGP)
Atresia of the external auditory canal  (IAGP)
Autosomal dominant inheritance  (IAGP)
Bifid uvula  (IAGP)
Bilateral breast hypoplasia  (IAGP)
Bilateral choanal atresia  (IAGP)
Bilateral cleft lip  (IAGP)
Bilateral cleft palate  (IAGP)
Bladder diverticulum  (IAGP)
Bladder exstrophy  (IAGP)
Blepharitis  (IAGP)
Blepharophimosis  (IAGP)
Blue irides  (IAGP)
Bowel incontinence  (IAGP)
Breast aplasia  (IAGP)
Breast hypoplasia  (IAGP)
Camptodactyly  (IAGP)
Carious teeth  (IAGP)
Central diabetes insipidus  (IAGP)
Childhood onset  (IAGP)
Choanal atresia  (IAGP)
Chronic irritative conjunctivitis  (IAGP)
Chronic otitis media  (IAGP)
Cleft hard palate  (IAGP)
Cleft lip  (IAGP)
Cleft palate  (IAGP)
Cleft upper lip  (IAGP)
Clinodactyly of the 5th finger  (IAGP)
Coarse hair  (IAGP)
Conductive hearing impairment  (IAGP)
Congenital onset  (IAGP)
Conical tooth  (IAGP)
Conjunctivitis  (IAGP)
Corneal erosion  (IAGP)
Cryptorchidism  (IAGP)
Cutaneous photosensitivity  (IAGP)
Dacryocystitis  (IAGP)
Decreased number of sweat glands  (IAGP)
Decreased response to growth hormone stimulation test  (IAGP)
Delayed speech and language development  (IAGP)
Dental malocclusion  (IAGP)
Depressed nasal bridge  (IAGP)
Depressed nasal tip  (IAGP)
Dermal atrophy  (IAGP)
Disturbance of facial expression  (IAGP)
Dry skin  (IAGP)
Duplicated collecting system  (IAGP)
Dysphagia  (IAGP)
Ectodermal dysplasia  (IAGP)
Ectrodactyly  (IAGP)
Eczema  (IAGP)
Enamel hypoplasia  (IAGP)
Entropion  (IAGP)
Epispadias  (IAGP)
External ear malformation  (IAGP)
Facial hirsutism  (IAGP)
Fair hair  (IAGP)
Fine hair  (IAGP)
Finger syndactyly  (IAGP)
Fingernail dysplasia  (IAGP)
Freckling  (IAGP)
Furrowed tongue  (IAGP)
Generalized hypopigmentation  (IAGP)
Hallux valgus  (IAGP)
Hearing impairment  (IAGP)
High forehead  (IAGP)
Hydronephrosis  (IAGP)
Hydroureter  (IAGP)
Hyperconvex nail  (IAGP)
Hyperkeratosis  (IAGP)
Hyperpigmentation of the skin  (IAGP)
Hypodontia  (IAGP)
Hypogonadotropic hypogonadism  (IAGP)
Hypohidrosis  (IAGP)
Hypoplasia of penis  (IAGP)
Hypoplasia of the maxilla  (IAGP)
Hypoplasia of the thymus  (IAGP)
Hypoplastic labia majora  (IAGP)
Hypoplastic nipples  (IAGP)
Hypoplastic sacrum  (IAGP)
Hypospadias  (IAGP)
Impaired mastication  (IAGP)
Infantile onset  (IAGP)
Inguinal hernia  (IAGP)
Intellectual disability  (IAGP)
Intestinal malrotation  (IAGP)
Joint contracture of the hand  (IAGP)
Keratitis  (IAGP)
Lacrimal duct atresia  (IAGP)
Lacrimal duct stenosis  (IAGP)
Lacrimation abnormality  (IAGP)
Lip pit  (IAGP)
Low self esteem  (IAGP)
Lymphoma  (IAGP)
Macrodontia  (IAGP)
Malar flattening  (IAGP)
Malnutrition  (IAGP)
Maternal teratogenic exposure  (IAGP)
Megacystis  (IAGP)
Melanocytic nevus  (IAGP)
Microdontia  (IAGP)
Micropenis  (IAGP)
Microtia  (IAGP)
Multiple cafe-au-lait spots  (IAGP)
Muscular dystrophy  (IAGP)
Nail dysplasia  (IAGP)
Nail dystrophy  (IAGP)
Nail pits  (IAGP)
Narrow mouth  (IAGP)
Narrow nose  (IAGP)
Nasal speech  (IAGP)
Nasogastric tube feeding in infancy  (IAGP)
Nasolacrimal duct obstruction  (IAGP)
Nevus  (IAGP)
Non-midline cleft lip  (IAGP)
Oligodactyly  (IAGP)
Oligodontia  (IAGP)
Omphalocele  (IAGP)
Onychogryposis  (IAGP)
Oral cleft  (IAGP)
Oral-pharyngeal dysphagia  (IAGP)
Oval face  (IAGP)
Palate fistula  (IAGP)
Palmoplantar keratoderma  (IAGP)
Patchy alopecia  (IAGP)
Patent ductus arteriosus  (IAGP)
Peg-shaped maxillary lateral incisors  (IAGP)
Photophobia  (IAGP)
Pili canaliculi  (IAGP)
Polyhydramnios  (IAGP)
Poor suck  (IAGP)
Premature loss of permanent teeth  (IAGP)
Premature ovarian insufficiency  (IAGP)
Primary amenorrhea  (IAGP)
Progressive alopecia  (IAGP)
Prominent nasal bridge  (IAGP)
Prostate cancer  (IAGP)
Protruding ear  (IAGP)
Proximal placement of thumb  (IAGP)
Psoriasiform dermatitis  (IAGP)
Ptosis  (IAGP)
Recurrent otitis media  (IAGP)
Recurrent urinary tract infections  (IAGP)
Renal agenesis  (IAGP)
Renal dysplasia  (IAGP)
Renal hypoplasia/aplasia  (IAGP)
Schizophrenia  (IAGP)
Selective tooth agenesis  (IAGP)
Sensorineural hearing impairment  (IAGP)
Short stature  (IAGP)
Situs inversus totalis  (IAGP)
Skeletal dysplasia  (IAGP)
Skin ulcer  (IAGP)
Slow-growing hair  (IAGP)
Small for gestational age  (IAGP)
Small nail  (IAGP)
Small, conical teeth  (IAGP)
Sparse axillary hair  (IAGP)
Sparse body hair  (IAGP)
Sparse eyebrow  (IAGP)
Sparse eyelashes  (IAGP)
Sparse hair  (IAGP)
Sparse pubic hair  (IAGP)
Sparse scalp hair  (IAGP)
Specific learning disability  (IAGP)
Speech articulation difficulties  (IAGP)
Split foot  (IAGP)
Split hand  (IAGP)
Stenosis of the external auditory canal  (IAGP)
Submucous cleft soft palate  (IAGP)
Supernumerary maxillary incisor  (IAGP)
Supernumerary nipple  (IAGP)
Syndactyly  (IAGP)
Talipes equinovarus  (IAGP)
Taurodontia  (IAGP)
Thick eyebrow  (IAGP)
Thin skin  (IAGP)
Toe syndactyly  (IAGP)
Toenail dysplasia  (IAGP)
Tooth agenesis  (IAGP)
Transverse vaginal septum  (IAGP)
Triphalangeal thumb  (IAGP)
Umbilical hernia  (IAGP)
Uncombable hair  (IAGP)
Underdeveloped nasal alae  (IAGP)
Unilateral cleft palate  (IAGP)
Ureterocele  (IAGP)
Urethral atresia  (IAGP)
Urethral stenosis  (IAGP)
Vaginal dryness  (IAGP)
Velopharyngeal insufficiency  (IAGP)
Ventricular septal defect  (IAGP)
Vesicoureteral reflux  (IAGP)
Wide intermamillary distance  (IAGP)
Wide nasal bridge  (IAGP)
Widely spaced teeth  (IAGP)
Xerostomia  (IAGP)

References - curated
# Reference Title Reference Citation
1. A novel c.1037C > G (p.Ala346Gly) mutation in TP63 as cause of the ectrodactyly-ectodermal dysplasia and cleft lip/palate (EEC) syndrome. Alves LU, etal., Genet Mol Biol. 2015 Mar;38(1):37-41. doi: 10.1590/S1415-475738120140125. Epub 2014 Mar 17.
2. Proliferation and apoptotic rates and increased frequency of p63-positive cells in the prostate acinar epithelium of alloxan-induced diabetic rats. Arcolino FO, etal., Int J Exp Pathol. 2010 Apr;91(2):144-54. doi: 10.1111/j.1365-2613.2009.00696.x. Epub 2009 Dec 22.
3. Analysis of the p63 gene in classical EEC syndrome, related syndromes, and non-syndromic orofacial clefts. Barrow LL, etal., J Med Genet. 2002 Aug;39(8):559-66.
4. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Celli J, etal., Cell. 1999 Oct 15;99(2):143-53.
5. Molecular basis of EEC (ectrodactyly, ectodermal dysplasia, clefting) syndrome: five new mutations in the DNA-binding domain of the TP63 gene and genotype-phenotype correlation. Clements SE, etal., Br J Dermatol. 2010 Jan;162(1):201-7. doi: 10.1111/j.1365-2133.2009.09496.x. Epub 2009 Nov 9.
6. Clinical Variability in a Family with an Ectodermal Dysplasia Syndrome and a Nonsense Mutation in the TP63 Gene. Eisenkraft A, etal., Fetal Pediatr Pathol. 2015;34(6):400-6. doi: 10.3109/15513815.2015.1095261. Epub 2015 Oct 16.
7. Mutant p53: one name, many proteins. Freed-Pastor WA and Prives C, Genes Dev. 2012 Jun 15;26(12):1268-86. doi: 10.1101/gad.190678.112.
8. Impaired delta NP63 expression is associated with poor tumor development in transitional cell carcinoma of the bladder. He Y, etal., J Korean Med Sci. 2008 Oct;23(5):825-32.
9. Periacinar Clefting and p63 Immunostaining in Prostatic Intraepithelial Neoplasia and Prostatic Carcinoma. Kruslin B, etal., Pathol Oncol Res. 2006;12(4):205-9. Epub 2006 Dec 25.
10. DeltaNp63 protein expression in uterine cervical and endometrial cancers. Lin Z, etal., J Cancer Res Clin Oncol. 2006 Dec;132(12):811-6. Epub 2006 Jun 28.
11. DeltaNp63 expression is associated with poor survival in ovarian cancer. Marchini S, etal., Ann Oncol. 2008 Mar;19(3):501-7. Epub 2007 Nov 12.
12. Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63. McGrath JA, etal., Hum Mol Genet. 2001 Feb 1;10(3):221-9.
13. The corneal epithelial stem cell. Moore JE, etal., DNA Cell Biol. 2002 May-Jun;21(5-6):443-51.
14. p53 mutations in cancer. Muller PA and Vousden KH, Nat Cell Biol. 2013 Jan;15(1):2-8. doi: 10.1038/ncb2641.
15. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
16. TP63 mutation and clefting modifier genes in an EEC syndrome family. Ray AK, etal., Clin Genet. 2004 Sep;66(3):217-22.
17. Progression of prostate cancer from a subset of p63-positive basal epithelial cells in FG/Tag transgenic mice. Reiner T, etal., Mol Cancer Res. 2007 Nov;5(11):1171-9. Epub 2007 Nov 2.
18. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
19. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
20. RGD HPO Phenotype Annotation Pipeline RGD automated import pipeline for human HPO-to-gene-to-disease annotations
21. EEC (Ectrodactyly, Ectodermal dysplasia, Clefting) syndrome: heterozygous mutation in the p63 gene (R279H) and DNA-based prenatal diagnosis. South AP, etal., Br J Dermatol. 2002 Feb;146(2):216-20.
22. E-cadherin and p63 immunoexpression in dysplastic lesions and urothelial carcinomas of the bladder. Stepan A, etal., Rom J Morphol Embryol. 2009;50(3):461-5.
23. Anorectal malformation associated with a mutation in the P63 gene in a family with split hand-foot malformation. Su P, etal., Int J Colorectal Dis. 2013 Dec;28(12):1621-7. doi: 10.1007/s00384-013-1725-6. Epub 2013 Jun 5.
24. Diagnostic and prognostic impact of p63 immunoreactivity in renal malignancies. Tuna B, etal., Anal Quant Cytol Histol. 2009 Apr;31(2):118-22.
25. p63 Gene mutations in eec syndrome, limb-mammary syndrome, and isolated split hand-split foot malformation suggest a genotype-phenotype correlation. van Bokhoven H, etal., Am J Hum Genet. 2001 Sep;69(3):481-92. Epub 2001 Jul 17.
26. An allelic series of Trp63 mutations defines TAp63 as a modifier of EEC syndrome. Vernersson Lindahl E, etal., Am J Med Genet A. 2013 Aug;161A(8):1961-71. doi: 10.1002/ajmg.a.36074. Epub 2013 Jun 14.
27. Integrating expression-related SNPs into genome-wide gene- and pathway-based analyses identified novel lung cancer susceptibility genes. Wang Y, etal., Int J Cancer. 2018 Apr 15;142(8):1602-1610. doi: 10.1002/ijc.31182. Epub 2017 Dec 12.
28. Analysis of large phenotypic variability of EEC and SHFM4 syndromes caused by K193E mutation of the TP63 gene. Wei J, etal., PLoS One. 2012;7(5):e35337. doi: 10.1371/journal.pone.0035337. Epub 2012 May 4.
29. Insertion/deletion polymorphisms in the DeltaNp63 promoter are a risk factor for bladder exstrophy epispadias complex. Wilkins S, etal., PLoS Genet. 2012;8(12):e1003070. doi: 10.1371/journal.pgen.1003070. Epub 2012 Dec 20.
30. TP63 gene mutations in Chinese P63 syndrome patients. Yin W, etal., J Dent Res. 2010 Aug;89(8):813-7. doi: 10.1177/0022034510366804. Epub 2010 Apr 21.
Additional References at PubMed
PMID:8695800   PMID:8889548   PMID:9405685   PMID:9618472   PMID:9662346   PMID:9662378   PMID:9703973   PMID:9774969   PMID:9799226   PMID:9799841   PMID:10373484   PMID:10469295  
PMID:10485447   PMID:10657951   PMID:10744705   PMID:10805802   PMID:10839977   PMID:10935472   PMID:11106548   PMID:11181441   PMID:11181451   PMID:11238924   PMID:11248048   PMID:11278685  
PMID:11336476   PMID:11477076   PMID:11528512   PMID:11532371   PMID:11641404   PMID:11714701   PMID:11727253   PMID:11733180   PMID:11739646   PMID:11787035   PMID:11839669   PMID:11879774  
PMID:11893750   PMID:11925430   PMID:11929852   PMID:11932750   PMID:11957139   PMID:11971180   PMID:12037717   PMID:12086851   PMID:12102658   PMID:12357472   PMID:12358808   PMID:12368193  
PMID:12374749   PMID:12379767   PMID:12379768   PMID:12393879   PMID:12446779   PMID:12446784   PMID:12477932   PMID:12525544   PMID:12533521   PMID:12534798   PMID:12692135   PMID:12782800  
PMID:12788532   PMID:12815266   PMID:12939657   PMID:12954772   PMID:12969350   PMID:14519656   PMID:14555649   PMID:14599865   PMID:14654522   PMID:14654529   PMID:14656652   PMID:14684701  
PMID:14729977   PMID:14757278   PMID:15001991   PMID:15024707   PMID:15201986   PMID:15254760   PMID:15339933   PMID:15359011   PMID:15367673   PMID:15389254   PMID:15467455   PMID:15489334  
PMID:15489655   PMID:15529180   PMID:15539951   PMID:15551738   PMID:15578720   PMID:15611636   PMID:15761962   PMID:15846104   PMID:15875781   PMID:15922574   PMID:15944736   PMID:15965232  
PMID:15983386   PMID:15988020   PMID:15988026   PMID:16007146   PMID:16082248   PMID:16133456   PMID:16152605   PMID:16181796   PMID:16187309   PMID:16258268   PMID:16273188   PMID:16273287  
PMID:16283378   PMID:16319057   PMID:16319531   PMID:16322335   PMID:16324199   PMID:16343436   PMID:16375115   PMID:16398404   PMID:16406339   PMID:16410722   PMID:16413471   PMID:16417229  
PMID:16446369   PMID:16449968   PMID:16462763   PMID:16481749   PMID:16516862   PMID:16575619   PMID:16581802   PMID:16616891   PMID:16618808   PMID:16630179   PMID:16646404   PMID:16679535  
PMID:16681687   PMID:16681688   PMID:16715076   PMID:16740912   PMID:16831876   PMID:16842248   PMID:16908849   PMID:16979518   PMID:17018588   PMID:17050669   PMID:17106255   PMID:17122775  
PMID:17159913   PMID:17172858   PMID:17188034   PMID:17276940   PMID:17312919   PMID:17336302   PMID:17385050   PMID:17392828   PMID:17399686   PMID:17404570   PMID:17446929   PMID:17498688  
PMID:17499344   PMID:17521434   PMID:17525625   PMID:17581882   PMID: